Mercury Computer Systems is a best-of-breed provider of open, commercially developed, application-ready, multi-INT subsystems for the Intelligence, Surveillance and Reconnaissance (ISR) market. The company has more than 30 years of experience solving highly challenging computing problems in the defense industry, providing superior domain expertise in radar, EW/SIGINT, EO/IR, C4I and sonar applications. Throughout its history, Mercury has worked in concert with 26 prime contractors to successfully execute more than 300 deployments on programs such as Aegis, Global Hawk, JCREW, Patriot, Predator and SEWIP.

Mercury Computer Systems Selected to Sharpen Performance of Checked Baggage Inspection Systems

Mercury’s leadership in optimizing performance for complex image processing applications raises the image quality, reliability and efficiency of baggage

inspection systems used by homeland and transportation security teams around the world





Mercury Computer Systems Inc., (NASDAQ:MRCY), a trusted provider of commercially developed ISR subsystems, has been selected by a worldwide provider of security inspection systems to accelerate the performance of its high-capacity checked baggage scanning equipment. Mercury’s unique expertise in optimizing algorithms was applied to powerful graphics processing units (GPUs) which are designed into scalable, standards-based systems architecture. The optimized algorithms and Mercury’s advanced software framework will enable the scanning systems to deliver ultra-clear images, improving the reliability of results, increasing security and expediting the screening process at airports and other transportation hubs.

Initially Mercury will provide optimization for back-projection algorithms for performance on Intel x86 processors with GPGPUs serving as specialized co-processors. The company will also deliver a customized software framework to optimize data flow from the sensor to the processing engines and then to the display. The optimization will result in extremely clear images being fed to the threat detection algorithm, reducing the number of false positives and supporting high belt speeds.

Mercury first implemented GPGPUs in 2004 as part of a medical imaging application, and continues to deliver numerous GPGPU-based solutions, including various high performance intelligence, surveillance and reconnaissance (ISR) subsystems.

Mercury is based in Chelmsford, Massachusetts, and serves customers worldwide through a broad network of direct sales offices, subsidiaries, and distributors.

For more information on Mercury’s subsystem solutions, visit www.mc.com, or contact Mercury at (866) 627-6951 or info@mc.com .

Read full article and disclaimer at: http://crwewallstreet.com/?p=21568

Crown Equity Holdings Inc. (CRWE)

The Voice over Internet Protocol, or VoIP, offers wide solutions to small businesses. With VoIP, small businesses can save money and boost their communications competence.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21566

Crown Equity Holdings Inc. (CRWE)

Any small or medium company can enjoy the advantages of Voice over Internet Protocol small business solution. Due to the essential internet technology and other web-related tools involved, simple networked systems may simply be integrated. As a result, facilities are made available not just for large corporations, but to small businesses as well.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21562

LivePerson, Inc. (NASDAQ:LPSN) has been named among Fortune Magazine's annual list of the 100 Fastest-Growing Companies, a group that Fortune dubs the "world's supercharged performers." "We're proud to be recognized for the considerable growth LivePerson has achieved," said Rob LoCascio, CEO of LivePerson. "We believe our consistent growth has been fueled by our mission and the value we deliver to businesses through our platform. We were committed to providing the best real-time engagement technology to online businesses so they can meaningfully connect with their customers and foster greater brand loyalty."

Read full article and disclaimer at: http://crwewallstreet.com/?p=21557

Enzo Biochem Inc. (ENZ)

Gene therapy is a technique of biotechnology which is used to treat and diagnose diseases like cancer and Parkinson's disease. The mechanism of this technique is that the healthy genes are targeted in the body which either destroy the damaged cells or replace them. In some cases, the healthy genes make corrections in the genetic information and that is how the genes start functioning in the favor of the body.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21556

AngioDynamics, Inc. (Nasdaq:ANGO) announced the Company has completed patient enrollment in its multi-center European prospective NanoKnife(R) System trial (ONC-205) for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. The purpose of this Company-sponsored trial is to evaluate the safety and efficacy of the NanoKnife System for the treatment of early-stage HCC. Eligibility was based on subjects having one to three tumors of a size no greater than 3 cm. Study subjects are allowed one retreatment with the NanoKnife System.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21555

http://crwewallstreet.com/?p=21548






Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.

Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer health and animal products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow.

We have made it our mission to provide innovative, distinctive products and services that save and improve lives and satisfy customer needs, to be recognized as a great place to work, and to provide investors with a superior rate of return.



Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals

Merck (NYSE:MRK), known outside the United States and Canada as MSD, recently announced that the company has sold its 50 percent interest in the Johnson & Johnson--Merck Consumer Pharmaceuticals Co. joint venture (JJMCP) to Johnson & Johnson (J&J) affiliates, McNEIL-PPC, Inc., McNEIL MMP, LLC, and Johnson & Johnson, Inc. The venture between Merck and J&J was formed in 1989 to develop, manufacture, market and distribute certain over-the-counter (OTC) consumer products in the United States (U.S.) and Canada.

Merck decided to sell its interest in the joint venture to enable the company to fully focus on building the long-term growth prospects of the wholly-owned consumer products division that had been part of Schering-Plough Inc. prior to the 2009 merger. Under the agreement, Merck will receive a one-time payment of $175 million. Merck's rights to the Pepcid brand outside the U.S. and Canada are not affected by this transaction. Termination of the JJMCP venture also gives Merck greater freedom to operate in the OTC consumer sector, allowing Merck to fully exploit its pipeline of Rx-to-OTC switches as well as actively pursue OTC licensing activities in the U.S. and Canada.

Following the transaction, J&J will own the venture's assets which include the exclusive rights to market OTC Pepcid, Mylanta, Mylicon and other local OTC brands where they are currently sold in the U.S. and Canada. The partnership assets include a manufacturing facility in Lancaster, PA.

For more information, visit www.merck.com and connect with us on Twitter, Facebook and YouTube.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21548

Barrick Gold Corporation (NYSE:ABX) will declare third Quarter Results Release October 27th before market open, Conference Call and Webcast. October 27th 9:30 am ET. North American callers dial: 800-757-5680. International callers dial: 212-231-2930. A live webcast of the Conference Call will be accessible on Barrick's website at www.barrick.com.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21546

Arrow Electronics, Inc. (NYSE:ARW) announced that the company has successfully completed the all-cash tender offer to acquire Japan-based Chip One Stop (TSE:3343.to). Arrow will be acquiring approximately 94% of the common shares of Chip One Stop. All necessary regulatory approvals related to the tender offer have been received. Headquartered in Yokohama, Japan, Chip One Stop has offices throughout Japan and is focused primarily on supplying electronic components to design engineers. The company's sales for the latest fiscal year were approximately $47 million.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21544

Crown Equity Holdings Inc. (CRWE)

Telephones have been plugging in for over 100 years. Today, thanks to new technology and the way people are thinking of telecommunications, people are literally pulling the plug on their telephones.


VoIP stands for Voice over Internet Protocol and this technology is taking the world by storm. More American homes are including computers with High Speed Internet connections, and with high tech homes, exposure to all of the options available to home users are changing the way people think about communication.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21543

Enzo Biochem Inc. (ENZ)

Biotechnology is a very vast field and its applications are used in various fields of science such as agriculture and medicine. Medicine is using biotechnology techniques so much in diagnosing and treating different diseases. It also gives opportunities for the people to protect themselves from dangerous diseases. The field of biotechnology, genetic engineering, has introduced techniques like gene therapy, recombinant DNA technology and polymerase chain reaction which use genes and DNA molecules to diagnose diseases and insert new and healthy genes in the body which replace the damaged cells.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21539

Acuity Brands, Inc. (NYSE:AYI) announced that a market leader in innovative energy-efficient lighting, controls and daylighting solutions, has expanded its Sunoptics® high-performance prismatic daylighting portfolio with the introduction of the SEAMLIGHT(TM) Curbless Daylighting System ("SEAMLIGHT System"). The SEAMLIGHT System was designed for direct installation onto existing industrial standing seam roofing systems, creating new opportunities for the implementation of daylighting solutions. The Sunoptics high-performance prismatic skylights optimize indoor daylighting performance via a patented dome construction designed to capture more light at low sun angles, which maximizes the amount of light transmittance, while maintaining 100% diffusion and eliminating undesirable hot spots, glare and UV damage.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21538

Black Hills Corp. (NYSE:BKH) announced it will be hosting two webcasts of panel discussions being held during the company's meeting with analysts from 8 a.m. to 11:30 a.m. MDT on Tuesday, Oct. 4, 2011, and from 8 a.m. to 11:30 a.m. MDT on Wednesday, Oct. 5, 2011. The panel discussions will include presentations by business segment leaders that provide an overview of strategies, planned capital investments, and progress on key projects and growth initiatives. Those interested in participating in the live webcasts are encouraged to pre-register for the webcasts by accessing the links on the Black Hills Corp. website on http://www.blackhillscorp.com/ir/ir.htm.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21537

SYNNEX Corporation, a Fortune 500 corporation, is a leading business process services company, servicing resellers, retailers and original equipment manufacturers in multiple regions around the world. The Company provides services in IT distribution, supply chain management, contract assembly and business process outsourcing. Founded in 1980, SYNNEX employs over 10,000 full-time and part-time associates worldwide.

We’ve built a solid reputation for delivering customized, fully-integrated solutions, services, and support, including distribution, contract assembly, business process outsourcing, and logistics. We’re aligned with the top manufacturers in the IT industry to distribute products to more than 15,000 resellers throughout North America. Key suppliers include HP, Intel, Seagate, Microsoft, and Lenovo. Our product categories include IT systems, peripherals, system components, software, and networking products.



SYNNEX Corporation Reports Fiscal 2011 Third Quarter

Solid Revenue Growth and Record Third Quarter Profitability


SYNNEX Corporation (NYSE:SNX), a leading business process services company, announced financial results for the fiscal third quarter ended August 31, 2011.

“I am very pleased with our sales growth and significant margin expansion this past quarter. Our excellent results were driven by increased market share in our core commercial business, our continued focus and execution in key IT growth markets, and new client engagements in our services segment,” stated Kevin Murai, President and Chief Executive Officer. “Our investments in value-added services are gaining traction and continue to further differentiate us from our competitors.”

Fiscal 2011 Third Quarter Business Segment Highlights:

Distribution: Revenue from continuing operations was $2.54 billion, an increase of 17.9% over the prior fiscal year third quarter. The year ago third quarter included $77.4 million in revenue from the portion of the contract assembly business which was sold in the third fiscal quarter of 2010. The acquisition on December 1, 2010 of SYNNEX Infotec Corporation in Japan added $297.0 million to the fiscal 2011 third quarter revenue. Distribution income from continuing operations before non-operating items, income taxes and noncontrolling interest was $58.6 million, or 2.31% of distribution revenue compared with $47.9 million, or 2.23% in the prior fiscal year quarter.


Global Business Services (GBS): Revenue from continuing operations was $40.5 million, an increase of 30.7% over the prior fiscal year third quarter. The year ago third quarter included $4.8 million from NDS business which was sold on August 31, 2010. The revenue contribution from acquisitions made in late 2010 onward was $13.0 million in the fiscal third quarter. GBS income from continuing operations before non-operating items, income taxes and noncontrolling interest inclusive of a $4.1 million benefit from the credit adjustment to contingent M&A consideration was $7.9 million, or 19.58% of GBS revenue compared with $4.2 million, or 13.65% in the prior fiscal year quarter.

Additional information about SYNNEX may be found online at www.synnex.com.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21525

Global Hunter (GBLHF.PK)

Copper is found in most electrical or electronic-related devices. Copper offers a variety of advantages, making it one of the most widely used electrical conductor in the world. Copper cookware is widely known as being a great conductor of heat and an energy saver. Cooking with copper is preferred by many professional chefs and restaurants because they last a long time and can cook a wide array of foods.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21523

Rand Logistics, Inc. (Nasdaq:RLOG) announced that it successfully closed its public underwritten offering of 2,800,000 shares of common stock at $6.00 per share. The Company's proceeds from the offering, net of underwriter's commissions, were $16.1 million. Rand expects to use the net proceeds of the offering to partially fund the anticipated acquisition of two dry bulk carriers, one of which is a self-unloader, and for general corporate purposes. With respect to the anticipated acquisitions, Rand also announced that it has entered into agreements to purchase the two bulk carriers for a total purchase price of $25 million.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21522

Cleantech Transit Inc. (CLNO)

Organic matter manufactured by starts is referred to as biomass. With more and more governments seeking alternative sources of energy not only to protect the environment but also to cut down on their oil imports, biomass turns out to be a fantastic option. The solar power which remains constant caught in shoots is what may be converted into power. Biomass might be applied in a similar way we use fossil fuels, whether it is for generating current for our industries or homes or as fuel for our vehicles. Having said that, biomass can assist in production of liquid-waste fuels that satisfy our requirements.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21520

Golden Enterprises, Inc.'s (NASDAQ:GLDC) declared a quarterly dividend of $.03125 per share payable October 26, 2011 to stockholders of record as of October 3, 2011. Golden Enterprises, Inc. saw an increase in Net Sales from the first quarter of 2011 to the first quarter of 2012 of 4%. Net sales for the first quarter were $33,245,190 compared to $31,956,084 for the same period in the prior year. Despite this increase in sales, increased commodity costs impacted margins resulting in basic and diluted earnings per share decreasing from $.09 to $.06 during the first quarter.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21519

http://crwewallstreet.com/?p=21504








Nanometrics’ product lines offer an extensive array of proprietary technologies in optics, software and systems integration designed to meet the process control requirements of today’s advanced semiconductor technologies. These process control solutions are implemented on common metrology platforms that can be configured with a variety of measurement technologies, or as a single technology targeted for a specific process control application.

Nanometrics Wins Multi-System Order for Integrated Metrology

Major Korean Memory Manufacturer Chooses Nanometrics for CMP Process Control




Nanometrics Incorporated (Nasdaq:NANO), a leading supplier of advanced metrology systems, announced that its IMPULSE® integrated metrology optical critical dimension (OCD) and film analysis system has been selected by a major Korean memory manufacturer for chemical mechanical planarization (CMP) process control. The decision makes the Nanometrics IMPULSE system “tool-of-record” for CMP control of NAND Flash memory in high-volume manufacturing at the 2x nm node. The IMPULSE was selected over competitive offerings following an extended technical evaluation.

“Today’s demands on CMP process control absolutely require integrated solutions,” said Steve Bradley, Director of Nanometrics’ Integrated Metrology Business Unit. “The selection of the IMPULSE for this leading-edge application is evidence of our product’s high throughput, excellent reliability, extendibility, and seamless integration onto the CMP platform, as well as the customer’s confidence in Nanometrics’ global service and applications support teams.”

“The selection of our integrated metrology product combined with an earlier decision in favor of our fully-automated Atlas OCD platform firmly establishes Nanometrics as the principle supplier of OCD products to this customer for advanced technology process control metrology,” said Dr. Timothy J. Stultz, president and chief executive officer. “By working closely with our customers on product roadmaps and aligning our product development with their requirements, we benefit from long term partnerships while we contribute to their advanced technology development and production ramps.”

More about NANO at www.nanometrics.com.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21504

Stillwater Mining Company (NYSE:SWC) announced that it has withdrawn its previously announced proposed offering of senior notes due to unfavorable market conditions. Commenting on this decision, Francis R. McAllister, the Company's Chairman and CEO, observed, "The dramatic deterioration of the capital markets during the past week has led us to conclude that it would not be in the best interests of our shareholders to complete a financing under the terms currently available. We have ample cash liquidity available, in addition to our strong cash flow, to fully fund the approximately $165 million net cash portion of the Peregrine transaction, provide for our working capital needs and fund near term capital requirements.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21495

Enzo Biochem Inc. (ENZ)

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. Biotechnology also utilizes these products for manufacturing purpose. Modern use of similar terms includes genetic engineering as well as cell- and tissue culture technologies.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21484

Crown Equity Holdings Inc. (CRWE)

Almost all of the Voice over Internet Protocol providers offer excellent packages ranging from 100 minutes to unlimited minutes every month. With most VOIP providers there is no differentiating between long distance and local. The minutes count the same.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21483

Peoples Educational Holdings, Inc. (NASDAQ:PEDH) will announce its financial results for the first quarter ended August 31, 2011 on Thursday, October 6, 2011 before the market opens. The Company will hold a conference call the same day at 11:00am Eastern Time to discuss its results. Participating in the call will be Brian Beckwith, President and Chief Executive Officer, and Michael DeMarco, Executive Vice President and Chief Financial Officer. Conference Call and Webcast Details: Live Conference Call, Thursday, October 6, 2011 at 11:00am Eastern Time, US: 800-638-4930, International: +1-617-614-3944, Participant Passcode: 34921295.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21481

Crown Equity Holdings Inc. (CRWE)

Once you have a Voice over Internet Protocol system installed in your home, you can start making long distance and international calls, at the rates almost negligible and at times even free.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21480

Cleantech Transit Inc. (CLNO)

The major advantage of biomass is that it is renewable and considered carbon neural. Unlike fossil fuels biomass is part of the current natural carbon cycle so there is no long term net increase in carbon in the atmosphere when biofuels are burned.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21478

Majestic Gold Corp. (MJGCF.PK)

Gold is present in our lives in the shape of different jewels, watches or decorations. Men and women are equally aware of the beauty and the value of this metal associating it with fortune, glory, and royalty. But beauty is not the only feature of gold.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21477

General Finance Corporation (NASDAQ:GFN) announced its consolidated financial results for the fourth quarter and fiscal year ended June 30, 2011. The consolidated results include results from majority-owned Royal Wolf Holdings Limited ("Royal Wolf"), the leading provider of portable storage solutions in the Asia-Pacific regions of Australia and New Zealand, and wholly-owned Pac-Van, Inc., a prominent regional provider of portable storage and office containers, mobile offices and modular buildings in the United States.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21476

“There is a need for the simplification of treatment regimens featuring co-formulated, fixed-dose medicines as patients stay on therapy longer,” said John C. Martin, PhD, Chairman and Chief Executive Officer, Gilead Sciences, Inc. (Nasdaq:GILD), a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.



Gilead Sciences yesterday announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company’s Marketing Authorisation Application for the once-daily single-tablet regimen, Eviplera®, combining Gilead Sciences' Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)) with Tibotec Pharmaceuticals’ non-nucleoside reverse transcriptase inhibitor Edurant® (rilpivirine (as hydrochloride)) for the treatment of HIV-1 infection in antiretroviral-naïve adults with a viral load less than or equal to 100,000 HIV-1 RNA copies/mL.

The CHMP’s positive recommendation will be reviewed by the European Commission, which has the authority to approve medicinal products for use in the 27 countries of the European Union (EU). Gilead Sciences expects the European Commission to issue its decision on the marketing authorization for the Eviplera single-tablet regimen later this year.

The regulatory filing for the Eviplera single-tablet regimen is supported by 48-week data from two Phase 3 double-blind, active controlled, randomized studies (ECHO and THRIVE) conducted by Tibotec evaluating the safety and efficacy of rilpivirine compared to efavirenz in treatment-naïve HIV-1 infected adults. Both arms of the studies were administered with a background regimen, in which the majority of patients in the rilpivirine arm received Truvada. A bioequivalence study conducted by Gilead Sciences demonstrated that the co-formulated single-tablet regimen achieved the same levels of medication in the blood as emtricitabine plus rilpivirine plus tenofovir disoproxil fumarate.

For more information about Gilead Sciences, please visit: www.gilead.com

Read full article and disclaimer at: http://crwewallstreet.com/?p=21469

Enzo Biochem Inc. (ENZ)

The fusion of biology and technology is biotechnology. Biotechnology is the application of biological techniques to product research and development. In particular, biotechnology involves the use by industry of recombinant DNA, cell fusion, and new bioprocessing techniques.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21466

Majestic Gold Corp. (MJGCF.PK)

The incomparable value of gold throughout time on this planet is gauged in several ways not just financially but emotionally. Yes most people only see the dollar value of gold when its name is mentioned however there is also the eye opening amazement of a prospector discovering a huge gold nugget, the new wife accepting the ring signifying her union to her husband. Even the cold use of gold in the construction of modern electronics has shown that value also exists in its pure versatility.

Read full article and disclaimer at: http://crwewallstreet.com/?p=21464